Login to Your Account

Drug Development Looks Optogenetics in the Eye

Monday, September 30, 2013

Optogenetics, pioneered just three years ago for use in neuroscience experiments, is hitting its stride, as increases in venture and grant funding in the space attest. The research technique involves the delivery of genes or chemicals to activate neurons in response to light. The approach holds the potential to restore vision in people who have lost most or all of their photoreceptors to conditions such as retinitis pigmentosa (RP), regardless of the underlying genetic defect.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription